Catestatin Peptide Impedes Melanoma Progression and Drug Resistance by Reprogramming Oncogenic Signaling Pathways

Investigators reported for the first time the involvement of Catestatin peptide in carcinogenesis, with melanoma identified as unexplored and therapeutically relevant context.